Events
Discover upcoming events where you can connect with us! Join us to learn, network, and stay engaged with the latest in women’s health.
- October 23, 2025 12:00 am
Tri-Valley Life Sciences Summit
- Location:
- Rosewood Commons Conference Center | Pleasanton, CA
Radiant Oximetry was featured at the 2024 Tri-Valley Life Sciences Summit, Hosted and presented by Kaiser Permanente with Startup Tri-Valley and the City of Pleasanton.
- Event Date & Time
- October 23, 2025 12:00 am
- October 5, 2024 12:00 am
March of Dimes Celebrating Innovation
- Location:
- Computer History Museum 1401 North Shoreline Boulevard Mountain View, CA 94043 USA
Radiant Oximetry participated in March of Dimes Celebrating Innovation event in Mountain View, CA.
- Event Date & Time
- October 5, 2024 12:00 am
Raydiant Oximetry Launches IDE Pilot Study at LSU Health Shreveport to Advance Fetal Monitoring Technology
SAN RAMON, CA, November 5, 2025 — Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering innovations in fetal monitoring through advanced biophotonics and machine learning, today announced the initiation of an Investigational Device Exemption (IDE) Pilot Study at Louisiana State University Health Shreveport (LSUHS).
Raydiant Oximetry Successfully Completes 35-Patient Early Feasibility Study at Eastern Virginia Medical School at Old Dominion University
SAN RAMON, Calif., October 16, 2025 — Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering fetal monitoring innovations through advanced biophotonics and machine learning, today announced the successful completion of a 35-patient Early Feasibility Study (EFS) at Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School (EVMS)
Raydiant Oximetry Names Michael Nagel to Lead the Company into its Device Commercialization Stage as CEO
SAN RAMON, CA, UNITED STATES, September 16, 2025 — Raydiant Oximetry, Inc. a clinical-stage medical device company developing fetal monitoring innovations using advanced biophotonics and machine learning to improve outcomes during childbirth, today announced the appointment of Michael Nagel as Chief Executive Officer.
GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
GE HealthCare and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and technology of the two companies to advance fetal oxygen saturation monitoring technology with the goal of
Raydiant Oximetry Wins First Place in NIH RADx® Tech Fetal Monitoring Challenge Securing $750,000 in Prize Money
This challenge, co-sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Bill & Melinda Gates Foundation, aims to accelerate the development of advanced fetal monitoring technologies to improve fetal and neonatal outcomes.
Raydiant Oximetry Secures $1 Million Grant to Advance Fetal Monitoring Technology
Raydiant Oximetry, Inc., a clinical-stage medical device company developing innovations to keep mothers and babies safe during childbirth, has announced the receipt of a $1 million grant from the Bill & Melinda Gates Foundation.